Kognitic API
Kognitic API structures global oncology trial data into a single, continuously updated competitive landscape view for pharma commercial and medical strategy teams.
kognitic.comCrawled Nov 17, 2026
Kognitic API structures global oncology trial data into a single, continuously updated competitive landscape view for pharma commercial and medical strategy teams.
Kognitic Core structures global oncology trial data into a single, continuously updated competitive landscape view for pharma commercial and medical strategy teams.
Kognitic Outcomes turns published clinical evidence into normalized benchmarks across endpoints, populations, and treatment settings for pharma strategy teams.
ACTT Trial Results Indicate Remdesivir’s Efficacy Against Covid-19 The National Institutes of Health released interim data from the Phase 3 ACTT trial, which explores remdesivir for
Kognitic uses AI to analyze trends in oncology drug development.
American Cancer Society Releases Facts & Figures for 2019 The American Cancer Society has released the cancer facts and figures for 2019. With almost 17 million
Print Report Conferences Dashboard LinkedIn ASH 2023 Rapid Insights: Acute Myeloid Leukemia by Hunter Moody and Gayathri Devi ASH 2023 will feature the latest updates and
Insights on oncology and immunology clinical trials, forecasting, biomarker trends, competitive landscapes, and pharma pipeline analysis.
Signal briefs, case studies, and evidence-led analyses on competitive intelligence, clinical trial forecasting, and outcomes benchmarking in oncology.
Kognitic gives Data Science and Engineering teams a production-grade, machine-ready oncology data layer — consistent schemas, living taxonomies, continuous updates — instead of years of taxonomy work.
Kognitic gives executive leadership the structured foresight to allocate capital before the market prices it in — a single decision view of risk-adjusted confidence, competitive timing, and capital signal.
Kognitic structures clinical, competitive, and regulatory evidence into decision views for commercial, medical affairs, and data science teams in oncology.
Kognitic offers AI companies and vendors building products, agents, and models for life sciences a validated oncology evidence layer as a licensed foundation, instead of a multi-year build.
Kognitic gives BD, search and evaluation, and M&A teams a comparative view that holds up under diligence — before the room asks the hard question, not after.
Kognitic gives commercial strategy and competitive intelligence teams one live view of the landscape — structured and current on day one, instead of five sources and a spreadsheet.
Kognitic structures oncology intelligence for every pharma role — Commercial, Business Development, Medical Affairs, and Data Engineering.
Four questions that define oncology strategy. Kognitic structures competitive intelligence, clinical trial forecasting, portfolio risk assessment, and evidence benchmarking.
The company offers a preview of the Kognitic decision view tailored to a user’s therapeutic area, data, indications, and timelines.
Kognitic structures global clinical signals into decision ready intelligence for commercial and medical strategy teams.
How Kognitic collects, uses, shares, and protects information in connection with the Kognitic.com website and related marketing pages.